a day (250 mg/m 2 /dose) to the salvage chemotherapy. Marrow evaluation after two such cycles showed clearance of metastatic disease after which she received autologous stem cell transplant, radiation, and differentiation therapy as per protocol. No side effects were observed with the use of crizotinib during this period. She remains disease-free and off therapy for 2 months.
Chemo-resistant and relapsed neuroblastoma have a poor outcome with conventional multimodality therapy. Genomic studies have revealed two genes which can be therapeutically targeted, ALK and MYCN. Trials targeting ALK in neuroblastoma have progressed rapidly because of oral bioavailability of crizotinib and established safety profile in adult patients with ALK-positive nonsmall cell lung cancer (NSCLC).
Activating mutation in the tyrosine kinase domain of ALK was discovered as the most common cause of familial neuroblastoma and about 10-15% of sporadic neuroblastoma cases. [2] Crizotinib an ATP-competitive pyrimidinedamine derivative is a small molecule competitive inhibitor of ALK and mesenchymal-epithelial transition kinase that has shown extraordinary results with very little toxicity in various adult tumors harboring ALK translocations. Experience with crizotinib in children with refractory neuroblastoma in the COG trial ADVL0912 showed encouraging results with crizotinib monotherapy. [3] DNA sequencing for ALK mutations is the gold standard for diagnosing these mutations, however as the pretreatment frozen tissue is often not available as in our case IHC testing with D5F3 antibody for ALK expression or by FISH for ALK mutation is considered a valid alternative; although, it signifies only ALK amplification. [4] In our first patient, crizotinib monotherapy was able to achieve a complete response in a chemotherapy resistant setting and furthermore sustained this response for 32 weeks. In the second patient, crizotinib helped achieve remission in a primary refractory patient thereby making her eligible for autologous stem cell transplant.
Crizotinib therapy is well-tolerated and most common adverse events observed are minor which include nausea, diarrhea, vomiting, and vision disorders. Severe side effects are rare and include asymptomatic elevations in aminotransferase levels and fatigue. Neither of our patients showed any clinical or metabolic adverse effect at a dose of 250-265 mg/m 2 /dose over 2-9 months. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
Estimation of cancer risk due to exposure to lead contamination in Joss paper DOI: 10.4103/2278-330X.208857
Dear Editor, Contamination of heavy metal is a big concern in public health. Contact with heavy metal might imply the cancer risk. Lead is the heavy metal that is widely mentioned for its contamination and relationship to cancer. In the recent publication, the risk due to contact of lead contaminated in Ayurveda product is reported. [1] In real life, the contamination of lead can be seen in several objects. A forgotten object is Joss paper, which is widely used in Chinese communities around the world. The Joss paper is regularly used in religious practice by the Chinese and exposure to the lead on the Joss paper can be expected. According to a recent report, the level of lead contamination in each Joss paper is equal to 0.58-320.81 µg/g (ppm). [2] Here, the authors assess cancer risk from contact with lead contaminated Joss paper using the cancer risk assessment technique as used in the previous publication. [1] In the present model, individual lifetime cancer risk is equal to "concentration of contaminated lead in Joss paper × lifetime unit risk factor." As noted in the previous paper "unit risk factor of lead is equal to 1.2 ×10 −5 m 3 /µg" and "lead density equal to 11,340 kg/m 3 ." [1] According to this basic information, the derived individual lifetime cancer risk is equal to 6882.93-43655.82. This rate is considerable high comparing to the previously estimated rate in case of lead contaminated Ayurveda product. [1] Since Joss paper is widely used around the world, the cancer risk due to this ritual object is of concern.
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There are no conflicts of interest. Carcinomatous meningitis or leptomeningeal carcinomatosis (LMC) is defined as the infiltration of the pia mater and the arachnoid membrane by malignant cells. LMC is an underestimated complication of malignancy. [1] It is estimated to occur in 5-8% of cancer patients. [2] The incidence of LMC varies by the primary site of malignancy. LMC occurs in 78% of hematologic malignancies if central nervous system (CNS) directed treatment is not administered. [3] It is less common in solid tumors, of which lung cancer (9-25%), breast cancer (2-5%), and melanoma (up to 23%) are the most common. Gastric cancer complicated by LMC is very rare. [4] It is estimated to occur in 0.16% of all cases of gastric cancer, of which the majority (87%) have disseminated disease.
[5]
A 55-year-old man was diagnosed with Stage III gastric signet cell adenocarcinoma. After curative surgery in the form of total gastrectomy with Roux-en-Y esophagojejunostomy, he received adjuvant chemotherapy using epirubicin, oxaliplatin, and capecitabine for 6 cycles. One year later, he presented with a 1 week history of headache and vertigo. On examination, he was afebrile, weak but alert, and oriented. Examination of the cranial nerves was normal, sensory, and motor examination was normal without ataxia or nuchal rigidity. Upper gastrointestinal endoscopy and abdominal computed tomography scans were normal. Magnetic resonance imaging scan of the brain showed no abnormality. Electroencephalogram, Vitamin B12, thyroxin stimulation hormone, folic acid, and ammonia level were unremarkable. A diagnostic lumber puncture was performed revealing an opening pressure of 21 cm water. Cerebrospinal fluid (CSF) analysis showed white blood cell of 31 with 55% lymphocytes, 1% polymorphonuclear white cells, 36% atypical cells, protein of 120 mg/dL, and glucose of 85 mg/dL. Cytologic examination confirmed CSF involvement with adenocarcinoma with signet cell features [ Figure 1 ]. CSF microbiologic workup was negative. The patient was advised weekly triple intrathecal chemotherapy along with cranial radiotherapy, was given the first dose of triple intrathecal chemotherapy with methotrexate, Ara-C, and hydrocortisone along with best supportive care. He was lost to follow-up after the first dose and died at home about 4 weeks after discharge from the hospital (as ascertained from the patient's relative by phone).
LMC can be the first sign of relapse of gastric adenocarcinoma in the context of gastric cancer signifies poor prognosis. A unexplained headache in patients with solid tumors, even if locally controlled, should warrant consideration, and appropriate investigations for CNS and/or meningeal relapse.
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